The agreement builds on a clinical collaboration between the companies pursuant to which amezalpat was combined with ...

Building upon a successful end-of-Phase 2 meeting, received FDA "Study May Proceed" letter for pivotal Phase 3 trial of amezalpat (TPST-1120) combination therapy to treat first-line HCCAnnounced agree ...

Junaluska Sanitary District has been awarded $9.5 million from the N.C. Drinking Water State Revolving Fund to upgrade the ...